Link Pharma Chem Ltd.

Chemicals · Chemicals & Petrochemicals

BSE: 524748
₹28.50
▲ 0.00 (0.00%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
29/100
Weak
Valuation
100/100
Undervalued
Momentum
49/100
Neutral

QVM read Cheap on its own multiples Quality Weak, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹13 Cr
PE (TTM)
Data unavailable.
Price to Book
1.0
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-29.2
Free Cash Flow
₹0 Cr
as of March 31, 2026
Industry median ₹-0 Cr (238 companies)
EPS Growth (YoY)
-20.88%
as of June 30, 2026
Industry median 39.08% (220 companies)
Net Profit Growth (TTM)
-82.91%
as of June 30, 2026
Industry median 13.45% (212 companies)
Operating Revenue Growth (TTM)
16.32%
as of June 30, 2026
Industry median 7.93% (209 companies)
Profit Growth (YoY)
110.19%
as of Dec. 31, 2025
Industry median 23.11% (213 companies)
Revenue Growth (YoY)
12.19%
as of June 30, 2026
Industry median 17.49% (205 companies)
Current Ratio
1.01
as of March 31, 2026
Industry median 1.87 (237 companies)
Debt to Equity
0.57
as of March 31, 2026
Industry median 0.16 (224 companies)
Interest Coverage
1.02
as of June 30, 2026
Industry median 8.97 (221 companies)
Net Margin
1.01%
as of Dec. 31, 2025
Industry median 7.49% (212 companies)
Operating Margin (EBIT)
6.06%
as of June 30, 2026
Industry median 11.88% (214 companies)
Operating Margin (TTM)
2.05%
as of June 30, 2026
Industry median 9.75% (219 companies)
Return on Assets
-2.02%
as of March 31, 2026
Industry median 4.33% (217 companies)
Return on Capital Employed
4.84%
as of March 31, 2026
Industry median 10.34% (218 companies)
Return on Equity
-3.93%
as of March 31, 2026
Industry median 7.52% (219 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Debt to equity is below 0.5 (0.57)
  • No Return on equity is 15% or more (-3.9%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

2 of 5 met
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
0.0%
Low 27.5000 · High 29.9900
1W return
5.2%
Low 26.0000 · High 29.9900
1M return
5.2%
Low 25.0200 · High 32.5000
52W return
-31.3%
Low 25.0000 · High 32.5000
Lifetime High ₹73.2500 (Jan. 17, 2023)
Lifetime Low ₹3.7600 (Feb. 5, 2009)

Full price history and technicals →

EMA & SMA

Bullish3
Bearish3
5D
28.1
10D
28.0
20D
28.2
50D
31.6
100D
35.8
200D
41.8

Delivery and volume

Day avg. delivery
88.2%
Week avg. delivery
95.9%
Month avg. delivery
91.5%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

28.66
Pivot
First resistance29.83
Second resistance31.15
Third resistance32.32
First support27.34
Second support26.17
Third support24.85
Day RSI48.4
Day MFI81.3
Day MACD-0.86
Day MACD signal-1.36

Beta

1M-0.19
3M-0.25
1Y-0.25
3Y0.45

Price change analysis

↑ 5.2%
Over 1 Month
LowHigh
25.0232.50
↓ -31.3%
Over 3 Months
LowHigh
25.0032.50
↓ -31.3%
Over 6 Months
LowHigh
25.0032.50
↓ -31.3%
Over 1 Year
LowHigh
25.0032.50
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹9 Cr
Net profit (June 30, 2026)
₹— Cr
Basic EPS (June 30, 2026)
₹0.7200

Ranks #202 of 221 in Chemicals & Petrochemicals by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter52.40%
  • Mutual funds0.02%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 52.40% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 0.02% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
13 Mar 2026 RACHITA SAHU Bulk Sell 38,513 25.0600 BSE
13 Mar 2026 RISHIKESH S. THAKUR Bulk Buy 40,511 25.0900 BSE
24 Sep 2024 BERAZMANHORMAZDDOCTOR Bulk Sell 29,519 40.7300 BSE
16 Aug 2024 BERAZMANHORMAZDDOCTOR Bulk Sell 37,000 40.2900 BSE
1 Aug 2024 SHANKHAJIT SRIMANI Bulk Sell 25,000 41.6700 BSE
17 Jul 2023 JAI VINAYAK SECURITIES Bulk Buy 21,730 65.5800 BSE
17 Jul 2023 JAI VINAYAK SECURITIES Bulk Sell 22,230 65.2200 BSE
17 Jul 2023 HARDIKKUMAR MAIYAJIBHAI DESAI Bulk Buy 35,494 67.3100 BSE
17 Jul 2023 HARDIKKUMAR MAIYAJIBHAI DESAI Bulk Sell 35,494 66.2600 BSE
17 Jul 2023 KARANKUMAR KANUJI THAKOR Bulk Buy 36,800 68.0700 BSE

All bulk and block deals →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

  • Low Return on Equity (-3.9%)
  • Thin net profit margin (1.0%)

Opportunities

  • Trading below book value (PB 0.99)

Threats

  • Down 31.3% over the past year
  • Weak interest coverage (1.0x) -- limited cushion against rising rates

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Link Pharma Chem Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.